Literature DB >> 25684194

Inhibition screening method of microsomal UGTs using the cocktail approach.

Julieta Gradinaru1, Stéphanie Romand1, Laurent Geiser1, Pierre-Alain Carrupt1, Dany Spaggiari1, Serge Rudaz2.   

Abstract

A rapid method for the simultaneous determination of the in vitro activity of the 10 major human liver UDP-glucuronosyltransferase (UGT) enzymes was developed based on the cocktail approach. Specific substrates were first selected for each UGT: etoposide for UGT1A1, chenodeoxycholic acid for UGT1A3, trifluoperazine for UGT1A4, serotonin for UGT 1A6, isoferulic acid for UGT1A9, codeine for UGT2B4, azidothymidine for UGT2B7, levomedetomidine for UGT2B10, 4-hydroxy-3-methoxymethamphetamine for UGT2B15 and testosterone for UGT2B17. Optimal incubation conditions, including time-based experiments on cocktail metabolism in pooled HLMs that had been performed, were then investigated. A 45-min incubation period was found to be a favorable compromise for all the substrates in the cocktail. Ultra-high pressure liquid chromatography coupled to an electrospray ionization time-of-flight mass spectrometer was used to separate the 10 substrates and their UGT-specific glucuronides in less than 6 min. The ability of the cocktail to highlight the UGT inhibitory potential of xenobiotics was initially proven by using well-known UGT inhibitors (selective and nonselective) and then by relating some of the screening results obtained by using the cocktail approach with morphine glucuronidation (substrate highly glucuronidated by UGT 2B7). All the results were in agreement with both the literature and with the expected effect on morphine glucuronidation.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Azidothymidine (PubChem CID: 35370); Chenodeoxycholic acid (PubChem CID: 10133); Cocktail approach; Codeine (PubChem CID: 5284371); Etoposide (PubChem CID: 3310); Human liver microsomes; Isoferulic acid (PubChem CID: 736186); Levomedetomidine (PubChem CID: 60612); Phase II metabolism; Serotonin (PubChem CID: 5202); Testosterone (PubChem CID: 6013); Trifluoperazine (PubChem CID: 5566); UGT inhibition; UHPLC–TOF; d,l-4-Hydroxy-3-methoxymethamphetamine (PubChem CID: 3081137)

Mesh:

Substances:

Year:  2015        PMID: 25684194     DOI: 10.1016/j.ejps.2015.02.001

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  3 in total

1.  UGT1A1 and UGT1A9 Are Responsible for Phase II Metabolism of Tectorigenin and Irigenin In Vitro.

Authors:  Ji Li; Zhangyao Xu; Jifeng Gu
Journal:  Molecules       Date:  2022-06-26       Impact factor: 4.927

Review 2.  The Ontogeny of UDP-glucuronosyltransferase Enzymes, Recommendations for Future Profiling Studies and Application Through Physiologically Based Pharmacokinetic Modelling.

Authors:  Justine Badée; Stephen Fowler; Saskia N de Wildt; Abby C Collier; Stephan Schmidt; Neil Parrott
Journal:  Clin Pharmacokinet       Date:  2019-02       Impact factor: 6.447

Review 3.  Progress in Prediction and Interpretation of Clinically Relevant Metabolic Drug-Drug Interactions: a Minireview Illustrating Recent Developments and Current Opportunities.

Authors:  Stephen Fowler; Peter N Morcos; Yumi Cleary; Meret Martin-Facklam; Neil Parrott; Michael Gertz; Li Yu
Journal:  Curr Pharmacol Rep       Date:  2017-02-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.